Cart
sales@molnova.com
Ioxitalamic Acid
CAS No. 28179-44-4
Ioxitalamic Acid( Telebrix | Vasobrix | Acidum Joxitalamicum )
Catalog No. M27163 CAS No. 28179-44-4
Ioxitalamic Acid is a medical contrast medium and enhances the contrast of structures or fluids in the body in medical imaging.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 107 | In Stock |
|
| 5MG | 79 | In Stock |
|
| 10MG | 119 | In Stock |
|
| 25MG | 197 | In Stock |
|
| 50MG | 280 | In Stock |
|
| 100MG | 386 | In Stock |
|
| 200MG | 510 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameIoxitalamic Acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionIoxitalamic Acid is a medical contrast medium and enhances the contrast of structures or fluids in the body in medical imaging.
-
DescriptionIoxitalamic Acid is a medical contrast medium and enhances the contrast of structures or fluids in the body in medical imaging.
-
In Vitro——
-
In Vivo——
-
SynonymsTelebrix | Vasobrix | Acidum Joxitalamicum
-
PathwayOthers
-
TargetOther Targets
-
RecptorHuman Endogenous Metabolite
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number28179-44-4
-
Formula Weight643.942
-
Molecular FormulaC12H11I3N2O5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(=O)Nc1c(I)c(C(O)=O)c(I)c(C(=O)NCCO)c1I
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Choucair I, et al. Quantification of bile acids: a mass spectrometry platform for studying gut microbe connectionto metabolic diseases. J Lipid Res. 2020 Feb;61(2):159-177.
molnova catalog
related products
-
Dynorphin B (1-9)
Dynorphin B (1-9) is a neuropeptide and N-terminal cleavage product of dynorphin B. The formation of dynorphin B (1-9) is blocked by N-ethylmaleimide (NEM), a non-selective inhibitor of cysteine peptidases.
-
Glucagon-like peptid...
Glucagon-like peptide 1 (1-37), human (TFA) is a highly potent agonist of the GLP-1 receptor, it is a kind of pancreatic hormone synthesized by post-translational processing of proglucagon.
-
Ruplizumab
Ruplizumab (BG 9588), a humanized monoclonal IgG1κ antibody targeting CD40L (TNF Receptor), holds promise for research in systemic lupus erythematosus disease .
